Sol-Gel Technologies (SLGL) Common Equity (2016 - 2026)
Sol-Gel Technologies (SLGL) reported Common Equity of $51.4 million for Q1 2026, up 154.84% year-over-year from $20.2 million in Q1 2025, and up 125.36% quarter-over-quarter from $22.8 million in Q4 2025.
Sol-Gel Technologies (SLGL) Common Equity (2016 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has 11 years of Common Equity data on file, last reported at $51.4 million in Q1 2026.
- Common Equity for Q1 2026 came in at $51.4 million, up 154.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $51.4 million (up 154.84% YoY), and the FY2025 annual result was $22.8 million, down 20.93% from the prior year.
- Common Equity rose to $51.4 million in Q1 2026 per SLGL's latest filing, from $22.8 million in the prior quarter.
- Over five years, Common Equity peaked at $246.7 million in Q1 2023 and troughed at $20.2 million in Q1 2025.
- A 5-year average of $71.6 million and a median of $38.6 million in 2023 frame the typical range for Common Equity.
- The sharpest annual moves came in 2022 and 2024: Common Equity soared 495.17% in 2022, then tumbled 86.76% in 2024.
- A 5-year view of Common Equity shows it stood at $42.2 million in 2022, then retreated by 8.45% to $38.6 million in 2023, then retreated by 25.34% to $28.8 million in 2024, then decreased by 20.93% to $22.8 million in 2025, then jumped by 125.36% to $51.4 million in 2026.
- Business Quant data shows SLGL's Common Equity at $51.4 million in Q1 2026, $22.8 million in Q4 2025, and $26.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 35.63 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.42 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 13.21 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 11.87 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Sol-Gel Technologies | 207.80 Mn | 197.67 Mn | - | 51.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.41 Mn |
| Dec 31, 2025 | 22.81 Mn |
| Sep 30, 2025 | 26.03 Mn |
| Jun 30, 2025 | 31.88 Mn |
| Mar 31, 2025 | 20.17 Mn |
| Dec 31, 2024 | 28.85 Mn |
| Sep 30, 2024 | 34.71 Mn |
| Jun 30, 2024 | 34.90 Mn |
| Mar 31, 2024 | 32.65 Mn |
| Dec 31, 2023 | 38.64 Mn |
| Sep 30, 2023 | 43.13 Mn |
| Jun 30, 2023 | 48.30 Mn |
| Mar 31, 2023 | 246.68 Mn |
| Dec 31, 2022 | 42.21 Mn |
| Sep 30, 2022 | 47.47 Mn |
| Jun 30, 2022 | 233.59 Mn |
| Mar 31, 2022 | 233.22 Mn |
| Dec 31, 2021 | 55.59 Mn |
| Sep 30, 2021 | 41.44 Mn |
| Jun 30, 2021 | 39.25 Mn |